Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Min Vedal | Researchclopedia

Back to researchers

Min Vedal

Bristol-Myers Squibb (Switzerland)

21

Works

186

Citations

6

h-index

4

i10-index

Research Topics

Lymphoma Diagnosis and Treatment CAR-T cell therapy research Chronic Lymphocytic Leukemia Research

Affiliations

Bristol-Myers Squibb (United States)2022–2024

Hôpital 20 Août2023–2023

Bristol-Myers Squibb (Switzerland)2024–2026

Top Works

Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study

Franck Morschhauser,Saurabh Dahiya,et al.

2024112 citations

CNS Lymphoma Diagnosis and Treatment

Cutaneous lymphoproliferative disorders research

TRANSCEND FL: PHASE 2 STUDY RESULTS OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)

Franck Morschhauser,Saurabh Dahiya,et al.

202320 citations

OUTREACH: phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL

Yuliya Linhares,César O. Freytes,et al.

202415 citations

TRANSCEND FL: Phase 2 Study Primary Analysis of Lisocabtagene Maraleucel as Second-Line Therapy in Patients with High-Risk Relapsed or Refractory Follicular Lymphoma

Franck Morschhauser,Saurabh Dahiya,et al.

202311 citations

Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Transcend FL 2-Year Follow-up

Loretta J. Nastoupil,Saurabh Dahiya,et al.

20248 citations

Author Correction: Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study

Franck Morschhauser,Saurabh Dahiya,et al.

20247 citations

Results from Outreach: A Phase 2 Study of Lisocabtagene Maraleucel (Liso-cel) Administered As Outpatient (Outpt) or Inpatient (Inpt) Treatment in the Community/Nonuniversity Setting in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)

Yuliya Linhares,Cesar Freytes,et al.

20225 citations

IBCL-098 TRANSCEND FL: Phase II Study Results of Lisocabtagene Maraleucel (Liso-Cel) in Patients With R/R Follicular Lymphoma (FL)

Loretta J. Nastoupil,Saurabh Dahiya,et al.

20232 citations

Lisocabtagene Maraleucel (Liso-cel) in Patients with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL) Treated As Outpatients or Inpatients in the Community/Nonuniversity Setting: Patient-Reported Outcomes/Health-Related Quality of Life from the Outreach Study

Yuliya Linhares,Fei‐Fei Liu,et al.

20222 citations